Clinical Trial | By Helft G, Steg PG, OPTImal DUAL Antiplatelet Therapy Trial Investigators.
Clinical Trial | By Feres F, Costa RA, OPTIMIZE Trial Investigators.
Clinical Trial | By Hong SJ, Shin DH, IVUS-XPL Investigators.
Clinical Trial | By Lee BK, Kim JS, Lee OH et al.
AIMS - There are few randomised studies concerning the optimal duration of dual antiplatelet therapy (DAPT) for patients who receive a second-generation drug-eluting stent (DES). This trial aimed to investigate the safety of six-month compared with 12-month DAPT maintenance after second-generation DES implantation. METHODS AND RESULTS - A prospective, randomised, multicentre trial was performed a...
Clinical Trial | By M Brodmann, M Werner, the ILLUMENATE EU RCT Investigators.
OBJECTIVES - The aim of this study was to assess the safety and effectiveness of a next-generation low-dose drug-coated balloon (DCB) designed to optimize the amount of drug transferred into the vessel wall and to maximize the amount of time the drug resides in the vessel wall. BACKGROUND - Several randomized controlled studies evaluating various DCBs have demonstrated a significantly higher pat...